Astralis Ltd. (fka ASTR)

[Renee]

ASTR revoked.

http://sec.gov/litigation/admin/2011/34-65487.pdf

http://www.otcbb.com/asp/dailylist_detail.asp?d=10/05/2011&mkt_ctg=NON-OTCBB

[Renee]

ASTR SEC Suspension:

http://sec.gov/litigation/suspensions/2011/34-65277.pdf

http://sec.gov/litigation/admin/2011/34-65276.pdf

[Hopeful7]

That's to bad sounds like a huge break through! But unless you have big funding behind you or are happy enough to get a royalty for your inventions things go away.

[Hopeful7]

That's to bad sounds like a huge break through! But unless you have big funding behind you or are happy enough to get a royalty for your inventions things go away.

[lattitdude67]

not with comments like this on on his linkedin page

CSO, CEO and Chairman
ASTRALIS LTD

Biotechnology industry

June 2002 – Present (9 years)

Astralis is in stand by, I have no salary since August 2006 and my company is delisted in the pink sheet waiting for money from investors

http://www.linkedin.com/pub/jose-o-daly/13/43a/aa5

[SuperC]

hold, sometimes months go by

[Hopeful7]

Does this have any life?

[SuperC]

ASTR>007up

[SuperC]

ASTR.006 129kvs1k_vol10dayavg

[levelnever]

seeing some volume this morning.

[levelnever]

Summary of Patents

[levelnever]

A few interesting slides from Astralis business plan (2008)

[levelnever]

no worries on language. I think we can all understand that. Good DD is good DD. Will add you now.

[allezlOM]

Levelnever: thank you for your proposal, I accept it, but don`t forget I`m an european shareholder and my language isn`t perfect :)
Long in ASTR which is managed by a very professional CEO.

[levelnever]

$15+ long-term potential - Just to give an idea of what the potential of this stock could be with current share structure if their drug Psoraxine were to make it to market. The CEO has said that Psoraxine has been approved for an FDA Phase II retrial. If it were to make it to make it past Phase II, the company has estimated that it would have a valuation of $200-$300 million, which would put the stock with current share structure in the $2-$3 range. The most similar drug on the market would be Humira by Abbott Laboratories. In 2009, Humira had $1.4 billion in sales.

[levelnever]

This is a good, but old read on Manuel Tarabay, an Astralis director and how he came to work with Astralis. Currently he is one of the central players in the Astralis story, so it is important to know more about him. He continues to help organize funding from Switzerland.

http://www.otcjournal.com/archive/listserv/20010926-1.html

[levelnever]

Purified proteins from leishmania amastigotes-induced delayed type hypersensitivity reactions and remission of collagen-induced arthritis in animal models
Received: 30 September 2009 / Revised: 10 December 2009 / Accepted: 29 December 2009

[levelnever]

Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with leishmania antigens
Received: 12 June 2009 / Revised: 4 August 2009 / Accepted: 7 August 2009


There are some font problems in this article resulting from the PDF I have of it, but it should still give you a pretty good sense.

[levelnever]

Isolation of leishmania amastigote protein fractions which induce lymphocyte estimulation and remission of psoriasis
Received: 5 October 2008 / Revised: 24 February 2009 / Accepted: 2 March 2009

[levelnever]

Antigens from leishmania amastigotes induced clinical remission of psoriasis
Received: 4 June 2008 / Revised: 20 August 2008 / Accepted: 21 August 2008

[levelnever]

Before I attempt to put a full DD post together, I am going to post some of what I have so far. First off, I am going to put out there the four articles the CEO has published in the last year and a half. They are long reads, but if you want to be well versed in what is happening at Astralis I encourage you to read through them. Should give everyone a good base from which to look at other DD.

[ASK]

ASTR is on my watchlist for now.

Recently bought NGMC with attractive share structure.

[allezlOM]

with last friday move, next week could be huge for ASTR, the ask was @ 0.011...this area would be broken soon IMHO

[allezlOM]

lorel, here is part of your answer :
"Of the outstanding shares, up to 11,605,224 shares are freely tradable without restriction or further registration under the Securities Act" (FORM SB-2 October 12, 2005)
O/S : as of november 2007, 91.454.873 SHARES
This stock moves easily, very thin, been obliged to put 3 buy orders to get filled !

[ASK]

Does anyone know the # of o/s and float?

Thanks.

[levelnever]

Yeah KAC, plenty more to come on this one, accumulated alot of DD on it already, most of which I have not presented yet. Will attempt to get out a DD post by next week. People can make of it what they will, but one of the more interesting stories I've come across for a sub-penny.

[allezlOM]

additive interesting press release from september 2009 and published on january 2010 :
www.springerlink.com/content/2w12773146816730/

[$niper]

Lurking, very very interesting.

[allezlOM]

recent volume indicates us that something is brewing maybe.That`s a first positive sign for this old nugget, take a look @ the past chart, amazing....!
Nice that levelnever confirmed this company still in business in this hot sector, the best is to come imho .

[prado]

Just checking in here level. Trying to figure out what is going on.

[levelnever]

Link to a couple papers recently published by the CEO:

http://lib.bioinfo.pl/auid:10599345

[levelnever]

Came upon this stock two months ago on a volume spike, looked dead, but contacted CEO. He informed me it wasn't. Whether putting out this information does anything for the PPS or not, I am going to put a DD post out on this one, because the story deserves to be heard.

[levelnever]

CEO linkedin profile:

http://www.linkedin.com/pub/jose-o-daly/13/43a/aa5

[levelnever]

hmmm...